Upgrade to SI Premium - Free Trial

Charles River Labs (CRL) PT Lowered to $275 at Baird

November 3, 2022 6:41 AM
Baird analyst Eric W. Coldwell lowered the price target on Charles River Labs (NYSE: CRL) to $275.00 (from $277.00) while maintaining a Outperform rating.

Categories

Analyst PT Change

Next Articles